The authors declare that they have no competing interests.
CO conceived the study. CO, KH and OO designed the study. CO, OO and BU were involved in data collection and analysis. CO wrote the initial draft of the manuscript and all the authors participated in its finalization.
The level of access to intermittent preventive treatment for malaria in pregnancy (IPTp) in Nigeria is still low despite relatively high antenatal care coverage in the study area. This paper presents information on provider factors that affect the delivery of IPTp in Nigeria.
Data were collected from heads of maternal health units of 28 public and six private health facilities offering antenatal care (ANC) services in two districts in Enugu State, south-east Nigeria. Provider knowledge of guidelines for IPTp was assessed with regard to four components: the drug used for IPTp, time of first dose administration, of second dose administration, and the strategy for sulphadoxine-pyrimethamine (SP) administration (directly observed treatment, DOT). Provider practices regarding IPTp and facility-related factors that may explain observations such as availability of SP and water were also examined.
Only five (14.7%) of all 34 providers had correct knowledge of all four recommendations for provision of IPTp. None of them was a private provider. DOT strategy was practiced in only one and six private and public providers respectively. Overall, 22 providers supplied women with SP in the facility and women were allowed to take it at home. The most common reason for doing so amongst public providers was that women were required to come for antenatal care on empty stomachs to enhance the validity of manual fundal height estimation. Two private providers did not think it was necessary to use the DOT strategy because they assumed that women would take their drugs at home. Availability of SP and water in the facility, and concerns about side effects were not considered impediments to delivery of IPTp.
There was low level of knowledge of the guidelines for implementation of IPTp by all providers, especially those in the private sector. This had negative effects such as non-practice of DOT strategy by most of the providers, which can lead to low levels of adherence to IPTp and ineffectiveness of IPTp. Capacity development and regular supportive supervisory visits by programme managers could help improve the provision of IPTp.
FMOH: National Antimalaria Treatment Policy. 2005, Abuja, Nigeria: National Malaria and Vector Control Division, Federal Ministry of Health
National Population Commission and ICF Macro Nigeria Demographic and Health Survey 2008: National Population Commission (Abuja, Nigeria) and ICF Macro. 2009, Maryland USA: Claverton
WHO: A Strategic Framework for Malaria Prevention and Control during Pregnancy in the Africa Region. In Report AFR/MAL/04/01. 2004, Brazzaville: World Health Organization Regional Office for Africa
WHO : Health Services Coverage Statistics: Antenatal Care Coverage (Percentage). 2012, Geneva: World Health Organization
WHO UNICEF: Antenatal Care in Developing Countries: promises, achievements and missed opportunities. An analysis of trends, levels and differentials. 2003, Geneva: World Health Organization and UNICEF
Ashwood-Smith H, Coombes Y, Kaimila M, Bokosi M, Lungu K: Availability and use of sulphadoxine-pyrimethamine (SP) in pregnancy in Blantyre District. Malawi Med J. 2002, 14: 8-11.
Fawole AO, Onyeaso NC: Perception and practice of malaria prophylaxis in pregnancy among primary health care providers in Ibadan, Nigeria. West Afr J Med. 2008, 27: 92-96. PubMed
Akinleye SO, Falade CO, Ajayi IO: Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study. BMC Pregnancy Childbirth. 2009, 9: 28-10.1186/1471-2393-9-28. PubMedCentralCrossRefPubMed
National Bureau of Statistics: Federal Republic of Nigeria: 2006 Population Census. 2007, Abuja: Federal Government of Nigeria
Enugu State Ministry of Health: Malaria situation in Enugu state. 2008, Enugu, Nigeria: Malaria Control Unit,State Ministry of Health
FMOH: Annual Report of the National Malaria and Vector Control Division. 2008, Abuja, Nigeria: Federal Ministry of Health, 2009-
Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J: Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District. North-Eastern Tanzania. Malar J. 2005, 4: 31- PubMed
FMOH: National Drug Policy. 2005, Abuja Nigeria: Federal Ministry of Health
Marchant T, Nathan R, Jones C, Mponda H, Bruce J, Sedekia Y, Schellenberg J, Mshinda H, Hanson K: Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania. Malar J. 2008, 7: 260-10.1186/1475-2875-7-260. PubMedCentralCrossRefPubMed
Mubyazi GM, Bygbjerg IC, Magnussen P, Olsen O, Byskov J, Hansen KS, Bloch P: Prospects, achievements, challenges and opportunities for scaling-up malaria chemoprevention in pregnancy in Tanzania: the perspective of national level officers. Malar J. 2008, 7: 135-10.1186/1475-2875-7-135. PubMedCentralCrossRefPubMed
Mubyazi GM, Bloch P, Byskov J, Magnussen P, Bygbjerg IC, Hansen KS: Supply-related drivers of staff motivation for providing intermittent preventive treatment of malaria during pregnancy in Tanzania: evidence from two rural districts. Malar J. 2012, 11: 48-10.1186/1475-2875-11-48. PubMedCentralCrossRefPubMed
- Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors
Chima A Onoka
Obinna E Onwujekwe
Benjamin S Uzochukwu
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II